Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
ImmunityBio (NASDAQ: IBRX) Advances in Oncology: Gearing Up for ANKTIVA’s Commercial…
Oragenics, Inc (NYSE: OGEN) Surges 34% Amidst Webinar Announcement and Intranasal…
Safe & Green Holdings Corp (NASDAQ: SGBX): A Strong Surge Amid…
Nuburu Inc (NYSE: BURU) Surges Amid Exciting Developments
Sensus Healthcare (NASDAQ: SRTS): A Strong Start to 2024 with Impressive…
Finance
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows…
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Page 5
Biotech
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Amarin Corporation plc (NASDAQ:AMRN) Announces Q3 Results As VASCEPA Continues To Drive Revenue
Gavins Felicity
-
November 11, 2020
Kintara Therapeutics Inc (NASDAQ: KTRA) Posts Topline Read Out Of Phase 2 Clinical Trial Of VAL-083 To Treat Patients With Glioblastoma Multiforme
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Finalizes Patient Enrolment In Pivotal Phase 3 I/ONTAK Study
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma
Sesen Bio Inc (NASDAQ:SESN) Receives Approval Of CDE Of China For Its Drug – Vicineum to Treat BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Exelixis, Inc. (NASDAQ:EXEL) Submits to the FDA Supplemental New Drug Application...
Matt Wade
-
August 31, 2020
0
The Human Research Ethics Committee of Monash Health Grants an Approval...
Matt Wade
-
September 14, 2020
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Topline Results Of AT-GAA In Phase...
Ward Sport
-
February 22, 2021
0
TCR2 Therapeutics Inc. (NASDAQ: TCRR) Announces Expansion of Manufacturing Capacity With...
Kate Hudson
-
November 8, 2021
0
Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) Begins Phase 2 Clinical Study of Vixarelimab...
Gavins Felicity
-
December 28, 2020
0
1
...
4
5
6
...
327
Page 5 of 327
Recent Post
ImmunityBio (NASDAQ: IBRX) Advances in Oncology: Gearing Up for ANKTIVA’s Commercial...
Kate Hudson
-
May 18, 2024
0
In a major stride towards addressing bladder cancer, ImmunityBio, Inc. (NASDAQ: IBRX) has recently completed the manufacturing of a drug substance that...
Oragenics, Inc (NYSE: OGEN) Surges 34% Amidst Webinar Announcement and Intranasal...
May 17, 2024
Safe & Green Holdings Corp (NASDAQ: SGBX): A Strong Surge Amid...
May 17, 2024
Nuburu Inc (NYSE: BURU) Surges Amid Exciting Developments
May 17, 2024
Sensus Healthcare (NASDAQ: SRTS): A Strong Start to 2024 with Impressive...
May 12, 2024